Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Sep;134(3):302-6.

Immune response to second dose of MMR vaccine in Indian children

Sunil Gomber  1 , Shilpa Khanna Arora, Shukla Das, V G Ramachandran
Affiliations

Immune response to second dose of MMR vaccine in Indian children

Sunil Gomber et al. Indian J Med Res. 2011 Sep.

Abstract

Background & objectives: MMR vaccine in a two dose schedule has successfully eliminated measles, mumps and rubella from many developed countries. In India, it is not a part of national immunization programme but is included in the State immunization programme of Delhi as a single dose between 15-18 months. This prospective study was carried out to assess the extent of seroprotection against these three diseases in immunized children and to study the immune response to a second dose of MMR.

Methods: Consecutive children aged 4-6 yr, attending the immunization clinic of a tertiary care hospital in Delhi for routine DT vaccination, were enrolled. Second dose of MMR was given and pre- and post-vaccination antibody levels were compared.

Results: The pre-vaccination percentage seropositivity observed in the 103 children recruited, was 20.4 per cent for measles, 87.4 per cent for mumps and 75.7 per cent for rubella. Amongst the 84 children who were followed up after the second dose, the percentage seroprotection for measles rose from 21.4 (18/84) to 72.6 per cent (61/84) and 100 per cent became seroprotected to mumps and rubella.

Interpretation & conclusions: The percentage of children protected against measles was found to be alarmingly low which needs to be investigated. Though the observed protection against mumps and rubella was adequate, its durability was not known. The need for re-appraisal of the current MMR immunization policy is called for by carrying out longitudinal studies on a larger sample.

PubMed Disclaimer

Comment in

References

    1. Peltola H, Heinonen OP, Valle M, Paunio M, Virtanen M, Karanko V, et al. The elimination of indigenous measles, mumps and rubella from Finland by a 12-year, two dose vaccination program. N Engl J Med. 1994;331:1397–402. - PubMed
    1. Mason WH. Measles. In: Kliegman RM, Behrman RE, Stanton BF, Jenson HB, editors. Nelson textbook of pediatrics. 18th ed. Philadelphia Pa: Saunders Elsevier; 2007. pp. 1331–7.
    1. Job JS, John TJ, Joseph A. Antibody response to measles immunization in India. Bull World Health Organ. 1984;62:737–41. - PMC - PubMed
    1. Mumps virus vaccines. Wkly Epidemiol Rec. 2007;82:49–60. [No authors listed] - PubMed
    1. Singhal T, Amdekar YK, Agarwal RK, editors. IAP guidebook on immunisation, IAP Committee on Immunization 2007-2008. New Delhi: Jaypee Brothers Medical Publishers; 2009. Anonymous. Individual vaccines; pp. 16–98.

Publication types

Substances